Standout Papers
- Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout (2005)
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (2018)
- Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trial (2008)
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment (2011)
Immediate Impact
4 by Nobel laureates 35 from Science/Nature 64 standout
Citing Papers
Gout
2021 Standout
Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies
2021 Standout
Works of Michael A. Becker being referenced
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
2014
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michael A. Becker | 3291 | 5344 | 3562 | 209 | 10.1k | |
| Michael H. Weisman | 2154 | 742 | 1472 | 338 | 21.6k | |
| Karl Skorecki | 4115 | 2207 | 1196 | 208 | 9.5k | |
| Pietro Ghezzi | 7716 | 1152 | 1272 | 404 | 24.6k | |
| Ana Cristina Simões e Silva | 2194 | 986 | 968 | 367 | 10.1k | |
| Andrew Grey | 2705 | 1422 | 1510 | 262 | 13.1k | |
| Christian Jacobsen | 4197 | 1044 | 812 | 144 | 10.7k | |
| David B. Thomas | 1735 | 1436 | 929 | 213 | 8.8k | |
| Alex J. MacGregor | 2215 | 240 | 2430 | 287 | 14.7k | |
| John R. Bradley | 2918 | 413 | 1143 | 149 | 7.8k | |
| Eun‐Jung Rhee | 1916 | 640 | 1341 | 294 | 9.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...